Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

156.12
Delayed Data
As of Jan 13
 +0.76 / +0.49%
Today’s Change
133.64
Today|||52-Week Range
176.85
+6.78%
Year-to-Date
Donald Trump Just Leveled Drug Companies With These 4 Words
Jan 14 / MotleyFool.com - Paid Partner Content
Kissing the ring
Jan 12 / Investing Channel - Paid Partner Content
Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan 13 / Zacks.com - Paid Partner Content
3 Cheap Value Stocks to Buy Today
Jan 12 / MotleyFool.com - Paid Partner Content
Sanofi confident it can overturn Praluent patent ruling
Jan 12 / FT.com - Paid Partner Content
Laurel Grove Capital, LLC Buys AvalonBay Communities Inc, Accenture PLC, Time Warner ...
Jan 11 / GuruFocus News - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
Drug Stocks Find Trump Animus a Bitter Pill
Jan 12 / TheStreet.com - Paid Partner Content
Amgen: Phase III Data on Hyperparathyroidism Drug Published
Jan 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close155.36
Today’s open155.28
Day’s range154.89 - 157.21
Volume2,637,514
Average volume (3 months)3,729,541
Market cap$116.1B
Dividend yield2.95%
Data as of 01/13/2017

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+11.28%
Earnings growth (next 5 years)+8.20%
Revenue growth (last year)+6.49%
P/E ratio15.6
Price/Sales5.83
Price/Book4.19

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.29-0.40%
BIIBBiogen-3.02-1.05%
ILMNIllumina Inc-0.27-0.17%
ARIAARIAD Pharmaceutical...-0.02-0.08%
Data as of 01/13/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$2.79
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs